202 related articles for article (PubMed ID: 25560781)
21. Validation of Salivary Markers, IL-1β, IL-8 and Lgals3bp for Detection of Oral Squamous Cell Carcinoma in an Indian Population.
Singh P; Verma JK; Singh JK
Sci Rep; 2020 Apr; 10(1):7365. PubMed ID: 32355279
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of salivary metabolomics in oral leukoplakia and oral squamous cell carcinoma.
Sridharan G; Ramani P; Patankar S; Vijayaraghavan R
J Oral Pathol Med; 2019 Apr; 48(4):299-306. PubMed ID: 30714209
[TBL] [Abstract][Full Text] [Related]
23. Salivary Biomarkers for Detection of Oral Squamous Cell Carcinoma in a Taiwanese Population.
Gleber-Netto FO; Yakob M; Li F; Feng Z; Dai J; Kao HK; Chang YL; Chang KP; Wong DT
Clin Cancer Res; 2016 Jul; 22(13):3340-7. PubMed ID: 26847061
[TBL] [Abstract][Full Text] [Related]
24. Estimation of salivary lactate dehydrogenase in oral leukoplakia and oral squamous cell carcinoma: a biochemical study.
Patel S; Metgud R
J Cancer Res Ther; 2015; 11(1):119-23. PubMed ID: 25879348
[TBL] [Abstract][Full Text] [Related]
25. Saliva proteome profiling reveals potential salivary biomarkers for detection of oral cavity squamous cell carcinoma.
Wu CC; Chu HW; Hsu CW; Chang KP; Liu HP
Proteomics; 2015 Oct; 15(19):3394-404. PubMed ID: 26205615
[TBL] [Abstract][Full Text] [Related]
26. Immunosuppressive mediators of oral squamous cell carcinoma in tumour samples and saliva.
Gonçalves AS; Arantes DA; Bernardes VF; Jaeger F; Silva JM; Silva TA; Aguiar MC; Batista AC
Hum Immunol; 2015 Jan; 76(1):52-8. PubMed ID: 25500427
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of saliva and plasma cytokine biomarkers in patients with oral squamous cell carcinoma.
Lee LT; Wong YK; Hsiao HY; Wang YW; Chan MY; Chang KW
Int J Oral Maxillofac Surg; 2018 Jun; 47(6):699-707. PubMed ID: 29174861
[TBL] [Abstract][Full Text] [Related]
28. Estimation of salivary lactate dehydrogenase in oral squamous cell carcinoma, oral leukoplakia, and smokers.
Bhuvaneswari M; Prasad H; Rajmohan M; Sri Chinthu KK; Prema P; Mahalakshmi L; Kumar GS
J Cancer Res Ther; 2022 Dec; 18(Supplement):S215-S218. PubMed ID: 36510967
[TBL] [Abstract][Full Text] [Related]
29. Salivary lactate dehydrogenase levels in oral leukoplakia and oral squamous cell carcinoma: a biochemical and clinicopathological study.
Shetty SR; Chadha R; Babu S; Kumari S; Bhat S; Achalli S
J Cancer Res Ther; 2012 Jan; 8 Suppl 1():S123-5. PubMed ID: 22322730
[TBL] [Abstract][Full Text] [Related]
30. Salivary 8-hydroxy-2-deoxyguanosine, malondialdehyde, vitamin C, and vitamin E in oral pre-cancer and cancer: diagnostic value and free radical mechanism of action.
Kaur J; Politis C; Jacobs R
Clin Oral Investig; 2016 Mar; 20(2):315-9. PubMed ID: 26077895
[TBL] [Abstract][Full Text] [Related]
31. Salivary microRNAs in oral cancer.
Zahran F; Ghalwash D; Shaker O; Al-Johani K; Scully C
Oral Dis; 2015 Sep; 21(6):739-47. PubMed ID: 25784212
[TBL] [Abstract][Full Text] [Related]
32. Chronic periodontitis can affect the levels of potential oral cancer salivary mRNA biomarkers.
Cheng YL; Jordan L; Chen HS; Kang D; Oxford L; Plemons J; Parks H; Rees T
J Periodontal Res; 2017 Jun; 52(3):428-437. PubMed ID: 27549383
[TBL] [Abstract][Full Text] [Related]
33. Salivary cytokines as biomarkers of oral cancer: a systematic review and meta-analysis.
Chiamulera MMA; Zancan CB; Remor AP; Cordeiro MF; Gleber-Netto FO; Baptistella AR
BMC Cancer; 2021 Feb; 21(1):205. PubMed ID: 33639868
[TBL] [Abstract][Full Text] [Related]
34. Changes in oral microbial profiles associated with oral squamous cell carcinoma vs leukoplakia.
Hashimoto K; Shimizu D; Hirabayashi S; Ueda S; Miyabe S; Oh-Iwa I; Nagao T; Shimozato K; Nomoto S
J Investig Clin Dent; 2019 Nov; 10(4):e12445. PubMed ID: 31342659
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of salivary endothelin-1 levels in oral squamous cell carcinoma and oral leukoplakia.
Hoffmann RR; Yurgel LS; Campos MM
Regul Pept; 2011 Jan; 166(1-3):55-8. PubMed ID: 20727373
[TBL] [Abstract][Full Text] [Related]
36. Assessment of salivary endothelin-1 in patients with leukoplakia, submucous fibrosis, oral cancer and healthy individuals - a comparative study.
Ankita K; Shwetha V; Vanitha S; Reddy Sujatha S; Nagaraju R; Tupakula Pavan K
J Stomatol Oral Maxillofac Surg; 2019 Sep; 120(4):326-331. PubMed ID: 30858129
[TBL] [Abstract][Full Text] [Related]
37. Role of salivary biomarkers in early detection of oral squamous cell carcinoma.
Awasthi N
Indian J Pathol Microbiol; 2017; 60(4):464-468. PubMed ID: 29323056
[TBL] [Abstract][Full Text] [Related]
38. Expression of inducible nitric oxide synthase (iNOS) in oral precancer and oral squamous cell carcinoma: an immunohistochemical study.
Varghese SS; Sunil PM; Madhavan RN
Cancer Biomark; 2010-2011; 8(3):155-60. PubMed ID: 22012771
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of salivary MMP-9 in oral squamous cell carcinoma and oral leukoplakia using ELISA.
Pazhani J; Chanthu K; Jayaraman S; Varun BR
J Oral Maxillofac Pathol; 2023; 27(4):649-654. PubMed ID: 38304520
[TBL] [Abstract][Full Text] [Related]
40. Salivary IL-6 levels in oral leukoplakia with dysplasia and its clinical relevance to tobacco habits and periodontitis.
Sharma M; Bairy I; Pai K; Satyamoorthy K; Prasad S; Berkovitz B; Radhakrishnan R
Clin Oral Investig; 2011 Oct; 15(5):705-14. PubMed ID: 20563615
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
